Adenovirus Expressing p27KIP1 Induces Apoptosis Against Cholangiocarcinoma Cells by Triggering Fas Ligand on the Cell Surface

Hepato-Gastroenterology

Volumn 50, Issue 54, 2003, Pages 1847-1853

  Yamamoto, Kuniharu ^a   Katayose, Yu ^a   Suzuki, Masanori ^a   Unno, Michiaki ^a   Sasaki, Tsuyoshi ^a   Mizuma, Masamichi ^a   Shiraso, Satoru ^a   Ohtuka, Hideo ^a   Cowan, Kenneth H ^b   Seth, Prem ^c   Matsuno, Seiki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NEBRASKA MEDICAL CENTER   (United States)

^c Iowa Cancer Research Foundation   (United States)

Author keywords

Adenovirus; Apoptosis; Fas; Gene therapy; Ligand; p27kip1

Indexed keywords

ADENOVIRUS VECTOR; FAS LIGAND; MESSENGER RNA; NEUTRALIZING ANTIBODY; PROTEIN P27; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; FASLG PROTEIN, HUMAN; MEMBRANE PROTEIN; TUMOR SUPPRESSOR PROTEIN;

APOPTOSIS; ARTICLE; BILE DUCT CARCINOMA; CANCER CELL CULTURE; CARCINOMA CELL; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSOL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ADENOVIRUS; BILE DUCT TUMOR; BREAST TUMOR; CELL CULTURE; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC TRANSDUCTION; GENETICS; LUNG TUMOR; PATHOLOGY; PHYSIOLOGY;

ADENOVIRIDAE; APOPTOSIS; BILE DUCT NEOPLASMS; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CHOLANGIOCARCINOMA; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FAS LIGAND PROTEIN; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; GENE THERAPY; HUMANS; LUNG NEOPLASMS; MEMBRANE GLYCOPROTEINS; RNA, MESSENGER; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0345392853     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Suzuki M, Takahashi T, Ouchi K, Matsuno S: The development and extension of hepatohilar bile duct carcinoma. A three-dimensional tumor mapping in the intrahepatic biliary tree visualized with the aid of a graphics computer system. Cancer 1989; 64:658-666.
2. Suzuki M, Takahashi T, Ouchi K, Matsuno S: Per ineural tumor invasion and its relation with the lymphogenous spread in human and experimental carcinoma of bile duct: A computer-aided 3-D reconstruction study. Tohoku J Exp Med 1994; 172:17-28.
3. Sherr CJ: Cancer cell cycles. Science 1996; 274:1672-1677.
4. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994; 78:59-66.
5. Steeg PS, Abrams JS: Cancer prognostics: past, present and p27. Nat Med 1997; 3:152-154.
6. Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 1997; 3:222-225.
7. Esposito V, Baldi A, Luca AD: Prognostic role of the cyclin-dependant kinase inhibitor p27 in non-small cell lung cancer. Cancer Res 1997; 57:3381-3385.
8. Kip1 expression is associated with clinical outcome in advanced epithelial ovarian cancer: multivariate analysis. Clin Cancer Res 2000; 6:4816-4822.
9. kip1 combined with high levels of Ki-67 predict shortened disease-free survival in T1 and T2 invasive breast carcinomas. Int J Oncol 2001; 18:17-23.
10. Kip1 induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cells. Oncogene 1997; 14:2283-2289.
11. Waf1/Cip1 on cell growth, cell cycle, and apoptosis. Cell Growth Differ 1995; 6:1207-1212.
12. Katayose Y, Kim M, Rakkar AN, Li Z, Cowan KH, Seth P: Promoting apoptosis: a novel activity associated with the cyclin- dependent kinase inhibitor p27. Cancer Res 1997; 57:5441-5445.
13. Rakkar AN, Katayose Y, Kim M: A novel adenoviral vector expressing human Fas/CD95/APO-1 enhances p53-mediated apoptosis. Cell Death Differ 1999; 6:326-333.
14. Itoh N, Yonehara S, Ishii A: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66:233-243.
15. Nagata S: Apoptosis by death factor. Cell 1997; 88:355-365.
16. Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75:1169-1178.
17. Matsumura H, Shimizu Y, Ohsawa Y: Necrotic death pathway in fas receptor signaling. J Cell Biol 2000; 151:1247-1256.
18. Dhein J, Walczak H, Baumler C, Debatin KM, Krammer PH: Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 1995; 373:438-441.
19. Katayose Y, Kudo T, Suzuki M: MUC1-specific targeting immunotherapy with bispecific antibodies: inhibition of xenografted human bile duct carcinoma growth. Cancer Res 1996; 56:4205-4212.
20. Katayose D, Wersto R, Cowan K, Seth P: Consequences of p53 gene expression by adenovirus vector on cell cycle arrest and apoptosis in human aortic vascular smooth muscle cells. Biochem Biophys Res Commun 1995; 215:446-451.
21. Craig C, Kim M, Ohri E, Wersto R: Effects of adenovirus-mediated p16INK4A expression on cell cycle arrest are determined by endogenous p16 and Rb status in human cancer cells. Oncogene 1998; 16:265-272.
22. Kip1. Biochem Biophys Res Commun 1998; 253:672-677.
23. Kayagaki N, Kawasaki A, Ebata T: Metalloproteinase-mediated release of human Fas ligand. J Exp Med 1995, 182:1777-1783.
24. Loda M, Cukor B, Tam SW, Lavin P: Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med 1997; 3:231-234.
25. Mori M, Mimori K, Shiraishi T: p27 expression and gastric carcinoma. Nat Med 1997; 3:593.
26. Toyoshima H, Hunter T: p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 1994; 78:67-74.
27. Kiyokawa H, Kineman RD, Manova-Todorova KO: Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 1996; 85:721-732.
28. Li DM, Sun H: PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. Proc Natl Acad Sci USA 1998; 95:15406-15411.
29. Kip1 into cyclin E/CDK2 complexes. Cancer Res 1999; 59:2318-2323.
30. kip1: a strategy for breast cancer gene therapy. J Natl Cancer Inst 1998; 90:1836-1838.
31. Dao T, Huleatt JW, Hingorani R, Crispe IN: Specific resistance of T cells to CD95-induced apoptosis during S phase of the cell cycle. J Immunol 1997; 159:4261-4267.
32. Bossi G, Griffiths GM: Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nat Med 1999; 5:90-96.
33. Seino K, Kayagaki N, Okumura K, Yagita, H: Antitumor effect of locally produced CD95 ligand. Nat Med 1997; 3:165-170.